Compounds exhibiting calcium receptor antagonist activity that are safe and orally administrable having Formula (I) or pharmaceutically acceptable salts thereof
具有钙受体拮抗活性的化合物,其具有公式(I)或其药学上可接受的盐,且安全且可口服。
Indanyl compounds
申请人:Daiichi Sankyo Company, Limited
公开号:US08183272B2
公开(公告)日:2012-05-22
Compounds exhibiting calcium receptor antagonist activity that are safe and orally administrable having Formula (I) or pharmaceutically acceptable salts thereof: